• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度血脂异常流行病学趋势。

Trends in epidemiology of dyslipidemias in India.

机构信息

Department of Biochemistry, RUHS College of Medical Sciences, Rajasthan University of Health Sciences, Jaipur, Rajasthan, India.

Department of Statistics, Mathematics and Computer Science, Government SKN Agriculture University, Jobner, Jaipur, Rajasthan, India.

出版信息

Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S20-S28. doi: 10.1016/j.ihj.2023.11.266. Epub 2024 Feb 12.

DOI:10.1016/j.ihj.2023.11.266
PMID:38360457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11019332/
Abstract

Dyslipidemias are the most important coronary artery disease (CAD) risk factor. High total cholesterol and its principal subtypes: low-density lipoprotein (LDL) cholesterol and non-high-density lipoprotein (NHDL) cholesterol are the most important. Epidemiological and Mendelian randomization studies have confirmed role of raised triglycerides and lipoprotein(a). INTERHEART study reported a significant association of raised ApoB/ApoA1, total-, LDL-, and NHDL-cholesterol in South Asians. Prospective Urban Rural Epidemiology (PURE) study identified raised NHDL cholesterol as the most important risk factor. Regional and multisite epidemiological studies in India have reported increasing population levels of total-, LDL-, and NHDL cholesterol and triglycerides. India Heart Watch reported higher prevalence of total and LDL cholesterol in northern and western Indian cities. ICMR-INDIAB study reported regional variations in hypercholesterolemia (≥200 mg/dl) from 4.6 % to 50.3 %, with greater prevalence in northern states, Kerala, Goa, and West Bengal. Non-Communicable Disease Risk Factor Collaboration and Global Burden of Diseases Studies have reported increasing LDL- and NHDL-cholesterol in India. Studies among emigrant Indians in UK and USA have reported higher triglycerides in compared to Caucasians. Identification of regional variations and trends in dyslipidemias need more nationwide surveys. Prospective studies are needed to assess quantum of risk with CAD incidence.

摘要

血脂异常是冠心病(CAD)最重要的危险因素。总胆固醇及其主要亚型:低密度脂蛋白(LDL)胆固醇和非高密度脂蛋白(NHDL)胆固醇最为重要。流行病学和孟德尔随机化研究证实了升高的甘油三酯和脂蛋白(a)的作用。INTERHEART 研究报告了南亚人升高的 ApoB/ApoA1、总胆固醇、LDL 胆固醇和 NHDL 胆固醇之间存在显著相关性。前瞻性城市农村流行病学(PURE)研究确定升高的 NHDL 胆固醇是最重要的危险因素。印度的区域和多地点流行病学研究报告称,总胆固醇、LDL 胆固醇和甘油三酯的人群水平呈上升趋势。印度心脏观察报告称,印度北部和西部城市的总胆固醇和 LDL 胆固醇患病率较高。ICMR-INDIAB 研究报告称,高胆固醇血症(≥200mg/dl)的区域性差异从 4.6%到 50.3%,北部各州、喀拉拉邦、果阿邦和西孟加拉邦的患病率更高。非传染性疾病风险因素合作组织和全球疾病负担研究报告称,印度 LDL 和 NHDL 胆固醇呈上升趋势。在英国和美国的印度移民中进行的研究报告称,与高加索人相比,印度人的甘油三酯水平更高。需要更多的全国性调查来确定血脂异常的区域差异和趋势。需要前瞻性研究来评估与 CAD 发病率相关的风险程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/dad9777f95c7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/4da2c3b2bc27/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/93a189aa767b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/d7fff35fcb55/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/6f9c4322815a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/dad9777f95c7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/4da2c3b2bc27/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/93a189aa767b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/d7fff35fcb55/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/6f9c4322815a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/11019332/dad9777f95c7/gr5.jpg

相似文献

1
Trends in epidemiology of dyslipidemias in India.印度血脂异常流行病学趋势。
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S20-S28. doi: 10.1016/j.ihj.2023.11.266. Epub 2024 Feb 12.
2
Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population.印度城市人口中胆固醇脂蛋白、甘油三酯的长期趋势及血脂异常患病率
Lipids Health Dis. 2008 Oct 24;7:40. doi: 10.1186/1476-511X-7-40.
3
Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study.城市亚洲印度人中胆固醇脂蛋白与血脂异常患病率:一项横断面研究。
Indian Heart J. 2014 May-Jun;66(3):280-8. doi: 10.1016/j.ihj.2014.03.005. Epub 2014 Apr 16.
4
Recent trends in epidemiology of dyslipidemias in India.印度血脂异常的流行病学最新趋势。
Indian Heart J. 2017 May-Jun;69(3):382-392. doi: 10.1016/j.ihj.2017.02.020. Epub 2017 Mar 6.
5
Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study.固定剂量洛伐他汀与缓释烟酸联合用药在亚洲印度血脂异常患者中的疗效和安全性评估:一项多中心研究。
Vasc Health Risk Manag. 2006;2(1):87-93. doi: 10.2147/vhrm.2006.2.1.87.
6
Importance of Dyslipidemias in Very Premature Coronary Artery Disease in India: A Registry-based Study.印度极低龄冠状动脉疾病中血脂异常的重要性:一项基于注册的研究。
J Assoc Physicians India. 2024 Sep;72(9):14-18. doi: 10.59556/japi.72.0663.
7
Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.孤立性低高密度脂蛋白胆固醇是心血管疾病的危险因素吗?弗雷明汉后代研究的新见解。
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):206-212. doi: 10.1161/CIRCOUTCOMES.115.002436. Epub 2016 May 10.
8
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.美国接受他汀类药物治疗成年人中根据低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B划分的残余血脂异常:2009 - 2010年美国国家健康和营养检查调查
J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16.
9
Dyslipidemia and its association with meibomian gland dysfunction.血脂异常及其与睑板腺功能障碍的关联。
Int Ophthalmol. 2016 Aug;36(4):469-76. doi: 10.1007/s10792-015-0149-4. Epub 2015 Oct 29.
10
Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.载脂蛋白 B (ApoB) 与 LDL 胆固醇不匹配与未来的冠心病事件相关。
Circulation. 2014 Feb 4;129(5):553-61. doi: 10.1161/CIRCULATIONAHA.113.005873. Epub 2013 Dec 17.

引用本文的文献

1
Rural-urban differences in lipid abnormalities among middle-aged and older Indians.印度中老年人脂质异常的城乡差异。
BMC Public Health. 2025 Aug 22;25(1):2895. doi: 10.1186/s12889-025-22625-3.
2
The prevalence of vitamin D deficiency and its association to modifiable risk factors of cardiovascular disease among apparently healthy adults in Central Kerala.喀拉拉邦中部表面健康成年人中维生素D缺乏症的患病率及其与心血管疾病可改变风险因素的关联。
J Family Med Prim Care. 2025 Jun;14(6):2443-2451. doi: 10.4103/jfmpc.jfmpc_1899_24. Epub 2025 Jun 30.
3
Unveiling Cardiovascular Risk Among Older Adults in Eastern India: A Community-Based Cross-Sectional Study.

本文引用的文献

1
Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).印度代谢性非传染性疾病健康报告:ICMR-INDIAB 国家横断面研究(ICMR-INDIAB-17)。
Lancet Diabetes Endocrinol. 2023 Jul;11(7):474-489. doi: 10.1016/S2213-8587(23)00119-5. Epub 2023 Jun 7.
2
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology.作为性能指标的低密度脂蛋白胆固醇测量与控制的重要性:美国国家脂质协会和美国预防心脏病学会的联合临床观点。
Am J Prev Cardiol. 2023 Feb 27;13:100472. doi: 10.1016/j.ajpc.2023.100472. eCollection 2023 Mar.
3
揭示印度东部老年人的心血管风险:一项基于社区的横断面研究。
Cureus. 2025 May 29;17(5):e85063. doi: 10.7759/cureus.85063. eCollection 2025 May.
4
Chronic statin-use before PCI in acute coronary syndromes and in-hospital outcomes: ACC-NCDR registry in India.急性冠状动脉综合征患者PCI术前长期使用他汀类药物与住院结局:印度ACC-NCDR注册研究
Am J Prev Cardiol. 2025 Apr 19;22:100999. doi: 10.1016/j.ajpc.2025.100999. eCollection 2025 Jun.
5
Evaluating Dyslipidemia and Atherogenic Indices as Predictors of Coronary Artery Disease Risk: A Retrospective Cross-Sectional Study.评估血脂异常和致动脉粥样硬化指数作为冠状动脉疾病风险预测指标:一项回顾性横断面研究。
Cureus. 2024 Oct 10;16(10):e71187. doi: 10.7759/cureus.71187. eCollection 2024 Oct.
6
Clinical Expression of Familial Hypercholesterolemia in Patients from France and French Canada Carrying Identical-by-Descent Pathogenic Gene Variants: A Proof-of-Concept Study.携带同源致病基因变异的法国和法裔加拿大患者家族性高胆固醇血症的临床表型:一项概念验证研究。
J Clin Med. 2024 Sep 26;13(19):5725. doi: 10.3390/jcm13195725.
7
Exserolide J ameliorates lipid accumulation by regulating liver X receptor alpha and peroxisome proliferator-activated receptor alpha proteins.艾瑟洛内酯J通过调节肝脏X受体α和过氧化物酶体增殖物激活受体α蛋白来改善脂质积累。
Heliyon. 2024 May 23;10(11):e31861. doi: 10.1016/j.heliyon.2024.e31861. eCollection 2024 Jun 15.
8
Indian dyslipidaemia guidelines: Need of the hour.《印度血脂异常指南:当下之需》
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S2-S5. doi: 10.1016/j.ihj.2024.01.008. Epub 2024 Jan 12.
World Heart Federation Cholesterol Roadmap 2022.世界心脏联合会胆固醇路线图 2022 年版
Glob Heart. 2022 Oct 14;17(1):75. doi: 10.5334/gh.1154. eCollection 2022.
4
Escalating ischemic heart disease burden among women in India: Insights from GBD, NCDRisC and NFHS reports.印度女性缺血性心脏病负担不断加重:来自全球疾病负担研究、非传染性疾病风险因素协作组和全国家庭健康调查的见解
Am J Prev Cardiol. 2020 Jul 17;2:100035. doi: 10.1016/j.ajpc.2020.100035. eCollection 2020 Jun.
5
Update on apolipoprotein B.载脂蛋白 B 研究进展
Curr Opin Lipidol. 2021 Aug 1;32(4):226-230. doi: 10.1097/MOL.0000000000000754.
6
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?非高密度脂蛋白胆固醇还是载脂蛋白 B:预防动脉粥样硬化性心血管疾病,哪个指标更适合作为靶点?
Curr Cardiol Rep. 2020 Jun 19;22(8):67. doi: 10.1007/s11886-020-01323-z.
7
Expanding statin use for prevention of ASCVD in Indians: Reasoned and simplified proposals.扩大他汀类药物在预防 ASCVD 中的应用:合理且简化的建议。
Indian Heart J. 2020 Mar-Apr;72(2):65-69. doi: 10.1016/j.ihj.2020.03.015. Epub 2020 Apr 8.
8
Repositioning of the global epicentre of non-optimal cholesterol.非最佳胆固醇的全球中心位置的重新定位。
Nature. 2020 Jun;582(7810):73-77. doi: 10.1038/s41586-020-2338-1. Epub 2020 Jun 3.
9
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病:病理生理学、遗传学及治疗学见解:欧洲动脉粥样硬化学会共识小组的共识声明
Eur Heart J. 2020 Jun 21;41(24):2313-2330. doi: 10.1093/eurheartj/ehz962.
10
Clinical review on triglycerides.关于甘油三酯的临床综述。
Eur Heart J. 2020 Jan 1;41(1):99-109c. doi: 10.1093/eurheartj/ehz785.